Live Breaking News & Updates on Lenz Therapeutics|Page 2

Stay updated with breaking news from Lenz therapeutics. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

LENZ Therapeutics, Inc. (NASDAQ:LENZ) Director Purchases $15,000,075.27 in Stock

LENZ Therapeutics, Inc. (NASDAQ:LENZ – Get Free Report) Director Ra Capital Management, L.P. purchased 998,009 shares of the stock in a transaction that occurred on Thursday, March 21st. The stock was acquired at an average cost of $15.03 per share, for a total transaction of $15,000,075.27. Following the completion of the acquisition, the director now […] ....

Therapeutics Company Profile , Securities Exchange Commission , Graphite Bio Inc , Lenz Therapeutics Inc , Therapeutics Inc , Get Free Report , Director Ra Capital Management , Exchange Commission , Bio Inc , Lenz Therapeutics , Nasdaq Lenz , Insider Trading , Nsider Trades ,

Getting a Next-Generation Genome Editing Therapy for Sickle Cell Disease Back on Track

Getting a Next-Generation Genome Editing Therapy for Sickle Cell Disease Back on Track
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United States , Matt Porteus , Daniel Levine , Matt Portus , Matthew Porteus , Lenz Therapeutics , Kamau Therapeutics , Graphite Bio ,

Kamau Therapeutics Emerges from Stealth with Graphite Bio's Gene-Editing Portfolio

Kamau Therapeutics Emerges from Stealth with Graphite Bio's Gene-Editing Portfolio
globalgenes.org - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from globalgenes.org Daily Mail and Mail on Sunday newspapers.

United States , Jerry Cacia , Maria Roncarolo , Matthew Porteus , Jane Grogan , Contract Development , Manufacturing Organization , Meeting Of The American Society Hematology , Drug Administration , Rare Daily , Graphite Bio , Lenz Therapeutics , Investigational New Drug , American Society , Cell Disease ,

Five things for pharma marketers to know: Thursday, November 16, 2023

Sanofi explores consumer health spinoff; FTC warns trade groups, influencers about social media posts promoting aspartame; Graphite Bio agrees to merge with Lenz Therapeutics. ....

New York , United States , Israel General , New York Times , Washington Post , Rothschild Co , Canadian Sugar Institute , American Beverage Association , Federal Trade Commission , Lenz Therapeutics ,